当前位置：首页>产品中心>单抗/多抗>Anti-Human IL-3R alpha & CD3 epsilon Bispecific Reference Antibody|抗人IL-3Rα和CD3ε双特异性参考抗体(靶标：人IL-3受体α/CD3)
Anti-Human IL-3R alpha & CD3 epsilon Bispecific Reference Antibody|抗人IL-3Rα和CD3ε双特异性参考抗体(靶标：人IL-3受体α/CD3)
- 货号：RB9THB714046
- 价格：面议
- 点击：712
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Humanized |
| 克隆性 | Monoclonal |
| 抗体亚型 | VH-VL-VH'-VL' |
| 纯度 | >95% purity as determined by SDS-PAGE. |
| 纯化方式 | Purified by Nickel column. |
| 浓度 | 1mg/ml |
| 内毒素水平 | Please contact the lab for this information. |
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 种属反应性 | Human |
| 靶标 | IL-3R subunit alpha, IL-3 receptor subunit alpha, CD123, Interleukin-3 receptor subunit alpha, IL3R, IL-3R-alpha, IL3RA, IL-3RA, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell |
| 储存缓冲液 | 0.01M PBS, pH 7.4. |
| 稳定性和储存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| 表达系统 | Mammalian Cells |
| 登录号 | P26951 & P07766 |
| 背景信息 | Vibecotamab (XmAb®14045) is a tumor-targeted antibody that contains both a CD123 binding domain and a cytotoxic T-cell binding domain (CD3) in a Phase 1 clinical trial for the treatment of acute myeloid leukemia (AML) and other CD123-expressing hematologic malignancies. An XmAb Bispecific Fc domain serves as the scaffold for these two antigen binding domains and confers long circulating half-life, stability and ease of manufacture on vibecotamab. CD123 is highly expressed on AML cells and leukemic stem cells, and it is associated with poorer prognosis in AML patients. Engagement of CD3 by vibecotamab activates T cells for highly potent and targeted killing of CD123-expressing tumor cells. |
| 别名 | Bispecific, MGD-006, MGD006, RES234, S80880, 1664355-28-5 |
| 备注 | For research use only. Not suitable for clinical or therapeutic use. |
相关产品:
